Building Biotechnology Capabilities Across Africa
Delivering laboratory products, custom molecular biology solutions, and biomanufacturing expertise to accelerate scientific discovery.
Building Africa's Biotechnology Platform
From Market Access to Biomanufacturing to Advanced Therapeutics
Market Access → Biomanufacturing → Advanced Therapeutics
Genesis Biotechnologies, Inc. is building an integrated biotechnology platform designed to connect scientific expertise, commercial market access, local manufacturing, and advanced therapeutics.
Our Commercial Foundation
Genesis has served laboratories and researchers in Africa for more than 18 years. Our commercial operations, Genesis-branded products, customer relationships, and distribution capabilities provide an established foundation for expansion into biotechnology manufacturing and advanced therapeutics.
18+ Years
Serving scientific markets
Established Customers
Researchers, laboratories and institutions
Regional Market Knowledge
Direct understanding of African research needs
Commercial Infrastructure
Distribution and product-sourcing capabilities
Our Platform
01 Market Access
An Established Commercial Foundation
Genesis provides laboratory products and biotechnology supplies to researchers, universities, laboratories, and scientific organizations.
-
Customer relationships
-
Market intelligence
-
Distribution capability
-
Regional expansion platform
02 Biomanufacturing
Building Local Biotechnology Manufacturing
Africa remains highly dependent on imported biotechnology products. Genesis is developing pathways toward local production of selected high-value biological and biotechnology products through product development and manufacturing partnerships.
Biological Products
Selected research and biotechnology products
Manufacturing Partnerships
Access to specialized production capabilities
Regional Production
Reducing dependence on imported inputs
03 Advanced Therapeutics
Building Toward Advanced Genetic Medicines
Genesis is building toward next-generation genetic medicines, drawing on expertise in gene therapy, genome editing, and translational biotechnology
Gene Therapy
Viral-vector and genetic-medicine expertise
Genome Editing
Nonviral gene-editing approaches
Advanced Delivery
AAV and CRISPR-LNP manufacturing pathways through strategic partnerships
Our Unique Capabilities
Commercial Access
Established experience serving African scientific markets.
Scientific Expertise
Gene therapy, genome editing, genomics, and translational biotechnology.
Manufacturing Partnerships
Pathways toward local production and advanced biotechnology manufacturing.
Market Intelligence
Direct understanding of African laboratory and supply-chain challenges.
Regional Opportunity
A platform designed to expand from Ghana into West Africa and broader markets.
Our Opportunity
Africa faces a powerful convergence:
Growing biotechnology demand
+
High dependence on imported products
+
Increasing local manufacturing capability
+
Rapid innovation in advanced therapeutics
= A significant opportunity to build biotechnology capabilities in Africa
Genesis is positioned at the intersection of commercial market access, biotechnology manufacturing, scientific expertise, and emerging genetic-medicine technologies.
Our Roadmap
Commercial Foundation
ACT
Regional Market Expansion
Bio
manufacturing
Advanced Genetic Medicines
Global Biotechnology Platform
Partner With Genesis
Building biotechnology capabilities requires scientific expertise, manufacturing capacity, strategic capital, and institutional collaboration
Strategic Partners
Manufacturing, biotechnology, commercialization
Investors
Biotechnology, healthcare and emerging markets
Scientific Collaborators
Gene therapy, genome editing and biomanufacturing
Institutions
Research, education and biotechnology capacity building
Company Facts
Corporate Structure
Delaware C-Corporation
Headquarters
Owings Mills, MD/Accra, Ghana
Current Operations
Ghana
Expansion Strategy
West Africa and broader African markets
Industry
Biotechnology
Strategic Focus
Scientific products, biomanufacturing, and advanced genetic medicines